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ABSTRACT Low-density lipoproteins (LDL) play a key role in the delivery of photosensitizers to tumor cells in photodynamic
therapy. The interaction of deuteroporphyrin, an amphiphilic porphyrin, with LDL is examined at equilibrium and the kinetics
of association/dissociation are determined by stopped-flow. Changes in apoprotein and porphyrin fluorescence suggest two
classes of bound porphyrins. The first class, characterized by tryptophan fluorescence quenching, involves four well-defined
sites. The affinity constant per site is 8.75  107 M1 (cumulative affinity 3.5  108 M1). The second class corresponds to
the incorporation of up to 50 molecules into the outer lipidic layer of LDL with an affinity constant of 2  108 M1.
Stopped-flow experiments involving direct LDL porphyrin mixing or porphyrin transfer from preloaded LDL to albumin provide
kinetic characterization of the two classes. The rate constants for dissociation of the first and second classes are 5.8 and 15
s1; the association rate constants are 5  108 M1 s1 per site and 3  109 M1 s1, respectively. Both fluorescence and
kinetic analysis indicate that the first class involves regions at the boundary between lipids and the apoprotein. The kinetics
of porphyrin-LDL interactions indicates that changes in the distribution of photosensitizers among various carriers could be
very sensitive to the specific tumor microenvironment.
INTRODUCTION
The retention of certain porphyrins by solid tumors, as
compared to normal surrounding tissues, has been recog-
nized for many years. This retention and the ability of these
molecules to generate short-lived toxic species upon light
irradiation are at the basis of a selective therapeutic ap-
proach, photodynamic therapy (PDT). In recent years, this
therapy has benefited from the development of lasers and
optical fibers and is now an established procedure for the
treatment of certain cancers (Pass, 1993; Dougherty et al.,
1998). Regulatory approval for PDT with a porphyrin-based
preparation, Photofrin, has been given. Second-generation
photosensitizers are now being developed with improved
light absorption in the red region (Boyle and Dolphin,
1996). Although various factors come into play in the over-
all efficiency of PDT, correlation has been established be-
tween the lipophilic character of photosensitizers and their
accumulation in tumors (Henderson et al., 1997) and, conse-
quently, their photosensitizing efficiency (Lavi et al., 2002).
It has been well established that the affinity of lipophilic
photosensitizers for serum lipoproteins, in particular low-
density lipoproteins (LDL), plays an important role in the
delivery of these drugs to tumor cells (Jori et al., 1984;
Reyftmann et al., 1984; Candide et al., 1986; Kessel, 1986).
The physiological role of LDL is providing cells with cho-
lesterol via cellular uptake. This is achieved by receptor-
mediated endocytosis resulting in the delivery of compo-
nents of LDL to the lysosomal compartment (Brown and
Goldstein, 1976). The distribution pattern of some porphy-
rins has been found to be correlated with the relative num-
bers of LDL receptors in different tissues (Kessel, 1986).
Several authors have pointed out an increased cholesterol
catabolism and over-expression of LDL receptors in tumor
cells (Gal et al., 1981; Vitols et al., 1992). The cellular
uptake and photoactivity of porphyrins have been increased
through potentialization of LDL catabolism by lovastatin
(Biade et al., 1993). By contrast, PDT-resistant tumor cells
exhibit low activity of LDL-related receptors (Luna et al.,
1995). These data taken together suggest that the selectivity
of lipophilic photosensitizing antitumoral agents arises from
a favored low-density lipoprotein receptor pathway
(Maziere et al., 1991). This specific pathway also plays a
key role in the mechanism of other PDT modalities used to
treat atherosclerotic lesions (de Vries et al., 1999) or to treat
choroidal neovascularization associated with age-related
macular degeneration (Miller et al., 1995).
Low-density lipoproteins are constituted of phospholip-
ids, cholesterol (esterified or not), triglycerides, and the
B100 apoprotein which contains, among other residues, 37
tryptophans and 151 tyrosines (Yang et al., 1986). A con-
sensus model has been proposed (Segrest et al., 2001)
consisting of a monolayer of phospholipids and cholesterol
surrounding a lipid core made of triglycerides and choles-
terol esters. Although the exact shape of LDL particles is
still debated, they can be viewed as spherical with a diam-
eter of 22 nm (Schumaker et al., 1994; Segrest et al., 2001).
A tentative representation is shown in Fig. 1.
Drugs bound to LDL could be distributed among the
three major components of these particles, i.e., the apoli-
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poprotein, the phospholipid envelope, and the lipid core.
The efficiency of LDL particles as carriers depends on the
overall number of exogenous molecules they can bind.
However, the integrity of the particle and, more particularly,
that of the receptor-binding site on apoB100 must be pre-
served. It is of particular importance to consider the inter-
actions from a dynamic point of view. The rates of exchange
of the photosensitizer between LDL and the other serum
proteins in blood must be considered. Indeed, the photosen-
sitizer distribution may be modified by the particular envi-
ronment provided by the interstitial compartment of neo-
plastic tissues (Jain, 1987), or even be modified in the
course of the LDL endocytosis process.
The capacity of LDL to bind some photosensitizers and
their functionality have been examined in a few studies
(Reyftmann et al., 1984; Candide et al., 1986; Beltramini et
al., 1987; de Smidt et al., 1993). Except for results on
isolated rabbit lipoprotein fractions (Beltramini et al.,
1987), no data are available concerning the distribution of
porphyrins in the various LDL compartments. To our
knowledge, no information about the dynamics of porphyrin
interactions with LDL has been published so far.
In the present paper, we investigate the interaction of an
amphiphilic porphyrin, deuteroporphyrin (DP), with LDL.
This dicarboxylic porphyrin was chosen because its struc-
ture corresponds to the framework of the components of
Photofrin, and approaches that of protoporphyrin, another
photosensitizer of therapeutic interest. Moreover, it can be
purified to a high degree and is less sensitive to photodeg-
radation than protoporphyrin. The different classes of bind-
ing sites are identified and characterized by monitoring the
intrinsic fluorescence of LDL or that of the porphyrin. The
dynamics of the interactions of LDL and porphyrin and
transfer to albumin are investigated using a stopped-flow
apparatus. All these processes are shown to be fast. This
approach has implications beyond the immediate problem
of photosensitizer transport by endogenous lipoproteins, but
also relates to the behavior of other drugs (Rudling et al.,
1983; Shaw et al., 1987) as well as the design of artificial
lipid particles for drug targeting (Rensen et al., 2001).
MATERIALS AND METHODS
Chemicals
All the experiments were carried out at pH 7.4 in saline phosphate buffer
(PBS) prepared from Na2HPO4/KH2PO4 (total phosphate, 9.57 10
3 M),
NaCl, 0.15 M and KCl, 2.68  103 M. Deuteroporphyrin (DP), the
structure of which is shown in Fig. 2, was prepared as described previously
(Brault et al., 1986). Its purity was determined to be better than 99% by
HPLC. A stock solution (103 M) was prepared in distilled tetrahydrofuran
(THF) and kept at 18°C. Experimental solutions were obtained by
evaporating an aliquot of the stock solution to make a film that was
dissolved in PBS. These were used without delay and renewed frequently.
FIGURE 1 (A) Postulated structure of LDL; (B) potential sites of por-
phyrin binding.
FIGURE 2 Structure of deuteroporphyrin (inset). Fluorescence emission
(top) and excitation spectra (bottom) of 5  108 M deuteroporphyrin in
phosphate buffer (dashed line), bound to 107 M LDL (solid line), and to
excess (5  106 M) HSA (dotted line). Excitation and emission wave-
lengths were set at 396 and 625 nm for emission and excitation spectra,
respectively.
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This procedure was found to minimize aggregation and adsorption of DP
on glass. The porphyrin solutions were handled in the dark to avoid any
photobleaching.
Human low-density lipoproteins (LDL) were purchased from Calbio-
chem (San Diego, CA), or were prepared by sequential ultracentrifugation
(Havel et al., 1955). The commercial material was conditioned in 0.15 M
NaCl aqueous solution at pH 7.4 with 0.01% EDTA. The protein content
of LDL solutions that we isolated was determined as described elsewhere
(Peterson, 1977). The integrity of the LDL after storage and after mixing
in the stopped-flow apparatus was assessed by acrylamide (7.5%) SDS-
PAGE electrophoresis and Tris-glycine native agarose gel electrophoresis
(1% agarose, 25 mM Tris base, 192 mM glycine, pH 8.4) according to
protocols described elsewhere (Carr et al., 2000). When stored at 4°C, the
stock solutions were found to be stable for about one month. Human serum
albumin (HSA) essentially fatty acid-free was purchased from Sigma (St.
Louis, MO), and stored at 4°C.
Measurements
Steady-state fluorescence measurements
Emission and excitation fluorescence spectra were recorded at 20°C using
a SPEX spectrofluorimeter (Edison, NJ). Recording generally commenced
2 min after the preparation of the solutions under study. Data were fitted by
using the Kaleidagraph software (Synergy Software, Reading, PA). The
Levenberg-Marquard algorithm was used for nonlinear curve fitting. The
Mathcad software (Mathsoft, Inc., Cambridge, MA) was used for numer-
ical simulations of porphyrins binding to LDL.
Kinetic measurements
Measurements were performed at 20°C with the aid of an Applied Photo-
physics (Leatherhead, UK) stopped-flow apparatus with mixing time of 1.2
ms. The mixing ratio was 1:1. The excitation light provided by a 150 W
xenon arc lamp was passed through a monochromator with slits generally
set to give a bandwidth of 4.65 nm. Fluorescence emission was collected
above 610 nm using a low-cut filter (Oriel, Palaiseau, France). The fluo-
rescence signal was fed on a RISC workstation (Acorn Computers, Cam-
bridge, UK) and analyzed using the software provided by the manufacturer.
Kinetic models
Interaction of porphyrin with LDL
Experimental results led us to consider two classes of porphyrins bound to
LDL (defined as class P and class L). In a first approximation, we assume
that binding of any molecule does not depend on the state of LDL
occupancy. In other words, pseudo-first-order conditions are assumed.
Also, the two binding classes are considered to be independent. Then,
PF LDL -|0
kaP
kdP
PP
PF LDL -|0
kaL
kdL
PL
where kaP and kdP are the association and dissociation rate constants for the
class P sites, kaL and kdL are those for DP binding to the lipid phase (class
L). PF stands for the free porphyrin in aqueous solution.
The set of differential equations describing the system is:
dPF/dt kdL PL kdP PP kaL kaP PF (1a)
dPL/dt kaL PF kdL PL (1b)
dPP/dt kaP PF kdP PP (1c)
where kaP and kaL are apparent association rate constants as functions of the
LDL concentration according to:
kaL kaL LDL
kaP kaP LDL
The solution can be easily found by using Laplace transforms (Connors,
1990). With the initial conditions PF(t0)  P0 and PL(t0)  PP(t0)  0,
the system is transformed into:
s PF P0kaP kaL PF kdL PL kdP PP
s PL kaL PF kdL PL
s PP kaP PF kdP PP
where s stands for the Laplace transform of the derivative function, and PP,
PL, and PF for the Laplace transforms of PP, PL, and PF.
It follows:
PF
P0 s
2 kdP kdL s kdP kdL
s D
PL
kaL P0 s kdP
s D
PP
kaP P0 s kdL
s D
where
D s2 kdP kdL kaP kaL s kdP kdL kaL
 kdP kaP kdL
 s k1 s k2
The inverse Laplace transforms yield the time dependence of PF, PL, or
PP concentrations. Biexponential functions with the same rate constants, k1
and k2, are obtained for the three species. These rate constants are the two
roots (with sign inversion) of the polynomial D. The rate constants k1 and
k2 (abbreviated k1,2) are:
k1,2
1
2
 	k
 	k2 4 kdP kdL kaL kdP kaP kdL

(2)
where
	k kdP kaP kdL kaL
For PF, the Laplace transform method yields:
PF A0 A1 expk1 t A2 expk2 t (3)
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where
A0 PF(t0)
kdL kdP
k1 k2
(4)
The amplitudes of these two exponential terms are:
A1 PF(t0)
k1
2 k1kdP kdL kdP kdL
k1k2 k1
(5)
A2 PF(t0)
k2
2 k2kdP kdL kdP kdL
k2k1 k2
(6)
A biexponential signal would be expected. However, it reduces to a
monoexponential when kdP  kdL, an approximation that appears to be
valid for the present system (see Results). Indeed, substituting kaP and kaL
by kaP  [LDL] and kaL  [LDL], and kdP  kdL by kd, we obtain:
k1  kd (7)
k2  kaP kaL LDL
 kd (8)
A1  PF(t0)
kd
2 2kd
2 kd
2
kd kaP kaL LDL

(9)
A2 PF(t0)
kaP kaL LDL

kd kaP kaL LDL

(10)
However, the numerator of Eq. 9, giving the amplitude A1, tends to zero.
In addition, the presence of the LDL term only in the denominator further
reduces the contribution of the first exponential at high lipoprotein con-
centration. The expressions describing the evolution of PL and PP have
been calculated in the same way. They also involve the rate constants k1
and k2, and the amplitude of the first exponential terms tends to zero under
the same conditions. As a consequence, when kdL and kdP approach one
another, only the second exponential characterized by the rate constant k2
is observed.
Numerical simulations using the Matcad software were carried out to
estimate the range of validity for this approximation. Biexponential signals
were generated with various kdL/kdP ratios and LDL concentrations accord-
ing to Eqs. 2–6. They were then fitted by a single exponential, and
residuals (signal minus curve fit) normalized to the total signal amplitude
were calculated. When kdL and kdP differ by a factor of 2.6 (the value
obtained from data analysis reported below), deviation cannot be distin-
guished from noise for LDL concentrations equal to or higher than 1 
108 M (see Results). When the ratio is 5, deviation starts to be visible for
a LDL concentration equal to 2  108 M. A ratio of 10 leads to deviation
in the all range of LDL concentrations investigated.
Transfer of porphyrin from LDL to HSA
The transfer of porphyrin from preloaded LDL to HSA was assumed to
occur via the aqueous phase according to the following equilibria:
PP -|0
kdP
kaP
PF -|0
kaH
kdH
PH
kdL) kaL
PL
where kaH is the pseudo-first-order association rate constant and kdH the
dissociation rate constant relative to porphyrin-HSA binding. It was further
assumed that under our experimental conditions, the interactions of the free
porphyrin with LDL and albumin are pseudo-first-order processes. Then,
the kinetics of the transfer process is described by the system of equations:
dPF/dt kdL PL kdP PP kdH PH
 kaL kaP kaH PF (11a)
dPL/dt kaL PF kdL PL (11b)
dPP/dt kaP PF kdP PP (11c)
dPH/dt kaH PF kdH PH (11d)
The solution of this system involves exponential terms with complex
analytical expressions. However, owing to the large LDL and HSA con-
centrations used experimentally, a considerable simplification can be ob-
tained. Indeed, the rate constants of the association of DP to albumin or
LDL are much larger than the dissociation constants. Consequently, the
steady-state approximation of Bodenstein holds, i.e., dPF/dt  0 (except
during a short initial period). Thus, we can express PF as a function of PP,
PL, and PH. Moreover, considering that in our experiments [HSA] 
[LDL], the rate constant of the association of DP to albumin (kaH  kaH 
[HSA]) is much larger than constants of the association with LDL. Then,
dPP
dt
 kaP kdPkaH  kdP  PP kaP kdLkaH  PL

kaP kdH
kaH
 PH
dPL
dt

kaL kdP
kaH
 PP kaL kdLkaH  kdL  PL

kaL kdH
kaH
 PH
dPH
dt
 kdP PP kdL PL
By using Laplace transforms with the initial conditions PF(t0) 
PH(t0)  0 and PL(t0)  PL0, PP(t0)  PP0 and neglecting terms that
become small when [HSA]  [LDL], we obtain:
PP
kaP kdLkaH  s  PL0 s2 kdL s PP0
s D
PL
kaL kdPkaH  s  PP0 s2 kdP s PL0
s D
PH
  kdP s kdP kdL
kdL kaL kdP
kaH
  PP0
 kdL s kdP kdL kdL kaL kdPkaH   PL0	
s  D
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with
D s2 kdL kdP s kdL kdP
 s kdL s kdP (12)
The inverse Laplace transforms give the expressions describing the
evolution of PH, PL, and PP as a function of time. Each expression consists
of the sum of one constant and two exponential terms. The rate constants
k1 and k2 are the roots (with sign inversion) of Eq. 12 for D  0.
k1 kdP (13)
k2 kdL (14)
For each of the exponentials noted 1 and 2, the contributions of the
various forms of the porphyrin (noted H, P, L) to the amplitudes (A) are:
AH,1
kdL kdP kaL kdLkaH   PP0 kaP kdLkaH  PL0
kdL kdP
AH,2
kaL kdP
kaH
 PP0 kdP kdL kaP kdPkaH   PL0
kdP kdL
AP,1
kdP kdL PP0
kaP kdL
kaH
 PL0
kdL kdP
AP,2
kaP kdL
kaH kdP kdL
 PL0
AL,1
kaL kdP
kaH kdL kdP
 PP0
AL,2
kdL kdP PL0
kaL kdP
kaH
 PP0
kdP kdL
It can be easily shown that the contributions of each form to the two
exponential terms are similar, even when the values of kdP and kdL are
close.
RESULTS
Steady-state measurements
Fluorescence spectra
The fluorescence emission spectra of DP in buffer, bound to
LDL or HSA, are shown in Fig. 2. The concentrations of
LDL (107 M) or HSA (5  106 M) were sufficient to
ensure total porphyrin binding (see equilibrium constants
below). The excitation wavelength was set at 396 nm, the
maximum of the excitation spectrum of DP bound to LDL.
The main emission band is shifted from 609 nm in PBS to
621 nm and 623 nm when the porphyrin is bound to LDL
and HSA, respectively. Albumin and LDL do not fluoresce
in this spectral range. As shown in Fig. 2, the emission and
excitation spectra appear to be different enough to easily
monitor changes in the porphyrin environment. A specific
peak around 280 nm can be noted in the excitation spectrum
of DP bound to LDL. No fluorescence excitation band
below 300 nm is observed for free deuteroporphyrin.
Upon excitation at 280 nm, LDL displays an intrinsic
fluorescence emission band around 330 nm due to trypto-
phan residues. As shown in Fig. 3, there is a significant
overlap between the emission spectrum of LDL and the
absorption spectrum of DP. Then, fluorescence resonance
energy transfer (FRET) from tryptophan residues of
apoB100 to DP is thus possible. According to Fo¨rster’s
equation, the efficiency of the transfer varies as the inverse
sixth power of the distance between the two partners and is
therefore strongly distance-dependent. The Fo¨rster’s dis-
tance that corresponds to half of the energy transferred has
been estimated to be 1.7 nm for a related porphyrin-
tryptophan couple (Moan et al., 1985). Hence, porphyrin
molecules close to tryptophan residues, i.e., bound to apo-
protein B100 or at the frontier between the protein and
lipids can be characterized by FRET.
Quantification of porphyrin binding to LDL by tryptophan
fluorescence quenching
The peak around 280 nm in the excitation spectrum of DP
bound to LDL corresponds to the excitation maximum of
tyrosine/tryptophan fluorescence indicating FRET. This
gives a clear indication of the existence of porphyrin sites
close to the protein. Concomitantly, as shown in Fig. 4 A,
the intrinsic fluorescence of apoprotein B100 is quenched
upon binding of porphyrin in a concentration-dependent
way. This first class of sites will be denoted as class P,
FIGURE 3 Fluorescence emission spectrum of LDL in the absence of
deuteroporphyrin (excitation 280 nm, left scale) and absorption spectrum
of LDL-bound deuteroporphyrin corrected for LDL absorption (right
scale). The overlap of spectra demonstrates the feasibility of fluorescence
resonance energy transfer (FRET).
3474 Bonneau et al.
Biophysical Journal 83(6) 3470–3481
hereafter. A linear relation between FRET efficiency and
the number of porphyrins bound to LDL is not expected,
however. Indeed, for each binding site, the efficiency will
depend on the distance and relative orientation of the por-
phyrin and the nearest tryptophan residues. Hence, we used
the method developed by Nishida (Halfman and Nishida,
1972) as follows. By definition, for any LDL concentration,
PF LDL  PTLDL  (15)
where  is the number of porphyrin molecules bound per
LDL molecule and PT the total porphyrin concentration.
The Nishida method is based on the existence of pairs of PT
and LDL concentrations yielding the same value of . Then,
for two pairs noted a and b it follows from the direct relation
between PF and  and from Eq. 15:
 
PTa/LDLa
LDLb
LDLa
PTb/LDLb
1
LDLb
LDLa
(16)
PF
LDLa LDLb
LDLa LDLb
PTb/LDLb PTa/LDLa
 (17)
It is further assumed that a value of  corresponds to a
unique value of the relative change of a protein property.
Here, this property is the tryptophan fluorescence expressed
as the ratio F/F0, where F and F0 are the fluorescence
intensities in the presence and absence of DP, respectively.
The quenching efficiency was measured, for two close
concentrations of LDL, as a function of the total DP con-
centration (Fig. 4 B). The decrease of F/F0 upon addition of
relatively low amounts of DP indicates the presence of
high-affinity sites. Pairs of PT and LDL concentrations
yielding the same value of F/F0 were selected, and the
values of  and PF were derived according to Eqs. 16 and
17. Then, results were plotted according to the Scatchard
method:

PF
 nKi Ki (18)
As shown in Fig. 5, the Scatchard plot led to the identi-
fication of about four sites. The mean intrinsic affinity per
site, Kpi, was found to be 9  10
7 M1. It can be noted that
similar results were obtained with commercial and labora-
tory-made LDL.
Porphyrin fluorescence changes upon binding to LDL
As shown in Fig. 2, binding of porphyrin to LDL leads to
important fluorescence modifications. The emission spec-
trum is characteristic of that for porphyrin in a lipidic
environment (Brault et al., 1986; Kuzelova and Brault,
1994). Preliminary fluorescence studies with increasing li-
poprotein concentrations showed that the binding capacity
of LDL greatly exceeds that of the four sites identified
above. Nevertheless, when the LDL concentration was large
enough to bind all the porphyrin molecules, emission and
excitation spectra of DP did not depend on the ratio DP/
LDL. Thus, the fluorescence characteristics of DP bound to
different locations are similar. Overall binding can be mon-
itored by changes in the porphyrin fluorescence without
distinguishing sites.
In the range of concentrations used, the fluorescence of
any solution is a linear combination of the fluorescence of
the individual porphyrin components at a given wavelength.
We considered the porphyrin free in solution (PF) and the
porphyrin bound to LDL (PB) with main peaks at 609 nm
FIGURE 4 Quenching of LDL intrinsic fluorescence (excitation wave-
length: 280 nm) upon deuteroporphyrin binding. (A) Fluorescence spectra
of LDL (4  108 M) as a function of DP concentration; PT/LDL: 0, 5, 7,
11, 15, 19 in the arrow direction; (B) relative fluorescence intensity (F/F0,
%) at 330 nm vs. PT/LDL. (}) [LDL]  6  10
8 M; (F) [LDL]  4 
108 M. Fluorescence intensities for PT  0 (F0) are normalized to 100%.
FIGURE 5 Quantification of binding of deuteroporphyrin to LDL fol-
lowed by changes of LDL intrinsic fluorescence at 330 nm (excitation
wavelength 280 nm). The Scatchard plot is obtained from data computed
according to the Halfman and Nishida method. The three symbols corre-
spond to LDL from various origins; (F, E) home-made LDL; () com-
mercial LDL.
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and 621 nm, respectively. We can write for these two
wavelengths:
F609 fB,609 PB fF,609 PF (19)
F621 fB,621 PB fF,621 PF (20)
The proportionality factors fF,609, fF,621, fB,609, and fB,621
were derived from calibration experiments on free DP and
LDL-bound DP (LDL in excess) at the two wavelengths,
respectively. Then, the concentrations PF and PB were cal-
culated from the above set of linear equations for any
solution of intermediate composition. The number of por-
phyrin molecules bound per LDL molecule, , was calcu-
lated accordingly. As shown in Fig. 6, the Scatchard plot,
/PF vs. , thus obtained shows a marked curvature indicat-
ing that more than one class of sites is involved.
The overall binding capacity of LDL has been estimated
by recording the fluorescence emission spectra of solutions
containing a fixed lipoprotein amount and increasing por-
phyrin concentrations. Bound and free DP concentrations
were calculated according to Eqs. 19 and 20. The bound DP
concentration increased, reaching a plateau at 55 porphy-
rin molecules per LDL, which corresponds to lipoprotein
saturation (data not shown).
Overall binding scheme
The number of class P sites being limited to about four,
other LDL compartments including the outer phospholipid
layer and the inner core should be involved (class L binding
sites). The overall binding would then be described by:

PF

nP KPi
1 PF KPi

nL KLi
1 PF KLi
(21)
where KPi, KLi, nP, and nL are the intrinsic microscopic
affinity constants and the corresponding number of sites for
the P and L classes, respectively.
In keeping with earlier studies (Beltramini et al., 1987),
the second interaction type would be better viewed as a
partition of DP between the bulk aqueous phase and the
lipidic phase of LDL (see Fig. 1). The above equation can
be rewritten using the same formalism but with the follow-
ing assumption: the porphyrin can reach a large number of
lipidic “sites” possessing a low intrinsic affinity (PF  KLi
 1). It follows that:
nL KLi
1 PF KLi
3 nL KLi
We can define a macroscopic affinity constant, KL  nL 
KLi. Then,

PF

nP KPi
1 PF KPi
 KL (22)
Experimental data have been fitted according to Eq. 22 by
nonlinear regression analysis, the overall affinity constant
being fixed at 5.8  108 M1, in agreement with results
presented below. The values of KPi, np, and KL thus derived
are given in Table 1. The theoretical fit is shown in Fig. 6
as a Scatchard plot.
The association of DP with LDL was also studied by
varying the LDL concentration for a constant porphyrin
concentration. Analysis of fluorescence data according to
the method previously used for liposomes (Brault et al.,
1986; Kuzelova and Brault, 1994) led to an overall associ-
ation constant of (5.8  1.2)  108 M1.
Kinetic measurements
Association of deuteroporphyrin and LDL
To follow the association of DP with LDL, different por-
phyrin solutions were mixed with a series of LDL solutions
in the stopped-flow apparatus and fluorescence changes
were recorded versus time. The porphyrin concentrations
FIGURE 6 Quantification of binding of deuteroporphyrin to LDL fol-
lowed by changes of DP fluorescence at 621 nm (excitation wavelength
396 nm). The curve is computed according to Eq. 22.
TABLE 1 Values of equilibrium and rate constants of association of deuteroporphyrin with the low-density lipoproteins
nP
Equilibrium Constants Rate Constants
KPi KP KL kaPi kaP kdP kaL kdL
9  107 M1* 3.6  108 M1* 5  108 M1s1 2  109 M1s1 5.8s1 3  109 M1s1 15s1
4*† 8.75  107 M1† 3.5  108 M1† 2  108 M1†
*Values calculated from the Scatchard plots obtained by following the quenching of lipoprotein intrinsic fluorescence.
†Values calculated from the Scatchard plots obtained by following the porphyrin fluorescence.
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were 1  108, 5  108, and 1  107 M, and those of
LDL 5  109, 1  108, 1.5  108, 2  108, and 3 
108 M after mixing. The number of porphyrin molecules
bound per LDL at sites of class P and in the lipid moiety
after completion of equilibria have been calculated by using
the equilibrium constants determined above. The values are
given in Fig. 7, A–C.
A typical fluorescence signal is shown in Fig. 8 A for the
more diluted porphyrin solution. The changes were found to
be fairly fast and the signal nicely fitted by a monoexpo-
nential (see Fig. 8 B). No other change was recorded over
seconds in stopped-flow experiments or over at least 2 h
when solutions were mixed manually and fluorescence re-
corded by using a conventional spectrofluorimeter. The
signals for the other sets of concentrations were very sim-
ilar, except the quality of the monoexponential fit was less
for the highest porphyrin/LDL ratios. At the lower porphy-
rin concentration, the sites of class P are far from being
saturated. On average, less than one site among four is
occupied. In the same way, the binding capacity of the lipid
phase greatly exceeds the number of bound porphyrins. In
these conditions, the interactions of DP with LDL are con-
sidered as pseudo-first-order processes.
According to the theoretical model presented in the pre-
vious section, in the most general case, the evolution of the
concentration of PF, PP, and PL, should be described by a
biexponential under pseudo-first-order conditions. How-
ever, when the dissociation rate constants for the two classes
of sites are close (kdP  kdL  kd), the amplitude of the
slower component vanishes. Even if these rate constants are
not equal, it would be very difficult to distinguish a small
slow component from the large fast signal. Numerical sim-
ulations (see above section) show that the dissociation rate
constants must differ by a factor of at least five to yield
significant deviation from monoexponential fit. An example
of simulation is given in Fig. 8 C. The rate constants (kdP 
5.8, kdL  15) determined by the method of transfer to
albumin described below were used. The relative amplitude
of the slow exponential was found to be only 2.3% of the
total. The comparison of the residuals obtained from the fit
of data (Fig. 8 B) and from simulation (Fig. 8 C) clearly
FIGURE 7 Stacked column representation of the number of porphyrins
per LDL at equilibrium under various experimental conditions. The num-
bers of porphyrins bound to class P sites and incorporated into the LDL
lipid phase are shown in black and grid areas, respectively. The number of
accessible class P sites is indicated by a dashed line. The overall binding
capacity of LDL is 55 porphyrin molecules. The values have been
computed using the equilibrium constants reported in Table 1.
FIGURE 8 Kinetics of binding of deuteroporphyrin to LDL. (A) Fluo-
rescence intensity changes recorded upon mixing LDL (final concentra-
tion: 2  108 M) with deuteroporphyrin (1  108 M); excitation
wavelength, 405 nm. Signals recorded by using two time scales are shown.
The best monoexponential fit leading to the observed pseudo-first-order
rate constant kobs is superimposed on the signals. (B) Normalized residuals
of the monoexponential fit of experimental data. (C) Normalized residuals
of the monoexponential fit of a biexponential signal simulated using the
rate constant values given in Table 1.
Porphyrin-Lipoprotein Interaction 3477
Biophysical Journal 83(6) 3470–3481
shows that the deviation introduced by the monoexponential
approximation cannot be distinguished from the experimen-
tal noise. Only one exponential is observed experimentally.
Thus, results were analyzed to a first approximation as a
pseudo-first-order single process leading to an observed rate
constant kobs that corresponds to k2 in our theoretical model.
Data shown in Fig. 9 are well-fitted by straight lines
according to,
kobs ka
obs LDL
 kd
obs (23)
Although all the values of kobs are depicted on the plot,
only those corresponding to 10% of overall site occu-
pancy were retained for the linear fit to obey pseudo-first-
order approximation. The apparent association rate constant
ka
obs was found to be fairly independent on experimental
conditions, with a value of ka
obs (4.65 0.10) 109 M1
s1. The intercept of the linear fit, kd
obs, ranges between 9
and 21 s1. The highest value was found for the highest
porphyrin concentration, i.e., when the number of molecules
incorporated into the lipid phase greatly exceeds that of
porphyrins bound to class P sites (see Fig. 7, A–C). This
suggests that kdL might be somewhat larger than kdP.
Transfer of deuteroporphyrin from LDL to albumin
To better approximate the values of kdP and kdL, the transfer
of the porphyrin from preloaded LDL to albumin in excess
was investigated. In previous studies, this approach was
found to be quite efficient to determine exit rate constants of
porphyrins from liposomes (Kuzelova and Brault, 1994;
Maman and Brault, 1998).
According to our theoretical model, the transfer from
LDL would be described by two exponentials under two
limiting conditions. First, the concentration of LDL must be
sufficient to bind most of the porphyrin molecules. Second,
a complete porphyrin transfer must be ensured by using
albumin in large excess (kaH  kaH  [HSA]  kaP, kaL).
Then, the exponential factors give kdL and kdP directly.
Remarkably, the amplitudes of the two exponentials are of
the same order of magnitude, contrary to observations for
the direct interaction of the porphyrin with LDL. Thus,
fitting is greatly facilitated.
Experimentally, solutions of porphyrin were first incu-
bated with LDL for 2 h at room temperature. The repartition
of porphyrins molecules between the two binding classes is
indicated in Fig. 7 D. They were then mixed in the stopped-
flow apparatus with solutions of albumin in large excess
(104 M after mixing). The transfer was followed by fluo-
rescence (see Fig. 2 for spectra) with the excitation wave-
length set at 396 nm, to yield the largest signal. A typical
trace is shown in Fig. 10 A. Clearly, the signal is better fitted
by two exponentials with almost equal amplitudes, as pre-
dicted by our model (see Fig. 10, B and C). As expected
from the spectra shown in Fig. 2, when excitation was set at
410 nm the fluorescence increased, but the rate constants
and the relative amplitudes of the two phases remained
unchanged. Rate constants of 5 s1 and 15 s1 were
obtained from the fits. On the basis of the results for the
interaction of DP with LDL described above, the lower
value was assigned to kdP.
The dissociation rate constants being known, it is possi-
ble to calculate the association rate constants from the
equilibrium constants derived independently from the Scat-
chard plots, assuming that K  ka/kd. Values of the rate
constants are summarized in Table 1.
As shown in Fig. 10 D, a slower phase with a rate
constant around 0.1 s1 was also detected. Its direction was
always opposite to that of the main signal, whatever the
excitation wavelength. The inversion of the signal was
observed at the same excitation wavelength (around 406
nm) for the fast and the slow phases. However, the ampli-
tude of the slow phase never exceeded 10% of the total
signal.
To further sustain the above models and the approxima-
tions made to analyze data, the kinetics of the interactions of
the porphyrin with LDL and the kinetics of the transfer of
the porphyrin from LDL to albumin were simulated by
using the Mathcad mathematical software. The program
involves the original sets of differential equations 1a–c and
11a–d without any assumptions and does not presuppose
pseudo-first-order conditions. The rate constants for albu-
min were taken as kaH 6.75 10
7 M1 s1 and kdH 3.5
s1 (Kuzelova and Brault, 1994). The known initial con-
centrations and estimates for the rate constants kaP, kaL, kdP,
and kdL were entered into the program. The simulated
curves were fitted by exponentials in the same way as
experimental data. The values of the rate constants kaP, kaL,
kdP, and kdL were adjusted so that the exponential factors
obtained from the fit of experimental traces and simulated
FIGURE 9 Plot of the observed pseudo-first-order rate constant (kobs)
versus LDL concentration. The porphyrin concentrations are (E) 1  108
M, () 5  108 M, and (‚) 1  107 M.
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curves were the same. The values of kaP, kaL, kdP, and kdL
that were retained allowed adequate simulations of all the
kinetics, including the transfer to albumin. These values
were found to be similar to those given in Table 1. The
validity of the approximations made and the fact that kdL is
higher than kdP were confirmed. However, simulations did
not predict a third slow phase. Thus, the aqueous phase
transfer model accounts for the fast steps but does not
explain the slower step. That will be discussed below.
DISCUSSION
The quenching of the intrinsic apoprotein fluorescence and
changes in the fluorescence of porphyrins upon interaction
with LDL made it possible to observe and characterize two
types of binding sites. The first set comprises about four
sites and involves quenching of tryptophan fluorescence.
The second set is not likely to involve discrete sites, al-
though saturation is observed when 50 porphyrin mole-
cules are incorporated. It could be better viewed as a solu-
bilization of the porphyrin in the LDL lipid phase.
The first set could involve sites localized at the protein
surface, or more deeply at the interface between the apo-
protein and the LDL lipid phase. In fact, the apoprotein
emission spectrum is peaking at 330 nm, a value typical of
tryptophan in a nonpolar environment (Lakowicz, 1983),
suggesting interactions with the LDL lipid phase. Also, the
fluorescence properties of deuteroporphyrin bound to class
P sites are very similar to those presented by the porphyrin
in a lipidic environment. This suggests that the first class of
sites involves the lipid protein-interface.
Further insight into the nature of binding processes of DP
to LDL can be obtained from analysis of kinetics. The
second-order rate constants for the association of the por-
phyrin with LDL can be compared to that of a process
limited by diffusion of these species in solution. The theo-
retical limit is given by:
kd 4RLDL RPDLDL DPN (24)
where RLDL and RP are the radii of the LDL and porphyrin,
and DLDL and DP are the diffusion coefficients of LDL and
porphyrin, respectively (Connors, 1990); N is Avogadro’s
number. The diffusion coefficient of porphyrin was esti-
mated to be (2.4  1.0)  1010 m2/s (Vever-Bizet and
Brault, 1993). The diffusion of LDL is much slower, with a
DLDL value of 2  10
11 m2/s (Lee and Alaupovic, 1974).
The radius of LDL is taken as 11  109 m (Schumaker et
al., 1994; Segrest et al., 2001). The radius of porphyrin is
5  1010 m. By using the above equation with appropriate
unit conversion, the diffusion limit is calculated to be 2.3 
1010 M1 s1. However, phospholipids cover only half the
LDL surface (Segrest et al., 2001), reducing the theoretical
limit to 1.2  1010 M1 s1. With a rate constant of 3 
109 M1 s1, the association of DP to the LDL lipid phase
approaches the diffusion limit. In previous experiments with
unilamellar vesicles made of pure phospholipids in the fluid
state, this limit was reached. The rate constant for the binding
to class P sites, 5 108 M1 s1, is50 times lower than the
diffusion limit. In fact, this decrease is less than expected if we
consider that binding involves discrete sites with a size com-
parable to that of the porphyrin. At least, the reduction should
correspond to the ratio between the surfaces of LDL and
porphyrin, i.e., 6  103. Binding of the porphyrin to some
larger regions at the boundary between the apoprotein and the
lipid phase appears more likely. The apoprotein is organized
around the particle and displays alternating 	-sheets and am-
phipathic 
-helices. The 	-sheets are in contact with irrevers-
ibly associated lipids likely involving cholesterol esters or-
FIGURE 10 Kinetics of the transfer of deuteroporphyrin from LDL to
HSA. (A) Fluorescence intensity changes recorded upon mixing LDL
preloaded with porphyrin and HSA. Final concentrations: DP  1.5 
107 M; LDL 2 108 M; HSA 1 104 M. Excitation wavelength
396 nm. (B) Residuals from the best monoexponential fit. The sum of the
squared differences between experimental data and the curve fit (2) is
0.093339. (C) Residual from the best biexponential fit. 2 is reduced to
0.078282. (D) Fluorescence intensity changes recorded over longer time.
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dered in a smectic phase. The amphipathic 
-helices are
associated with the surface phospholipids. Except for the N-
terminal globular domain, a large part of the apoprotein lies in
a hydrophobic environment offering possible binding areas
(Segrest et al., 2001).
The efficiency of lipoproteins as photosensitizer carriers
would be significantly increased if the sensitizer can be
solubilized within the lipid core. Such an incorporation
could be possible, even at neutral pH, for dicarboxylic
porphyrins. Indeed, the pK values of the carboxylic groups
are strongly shifted toward higher values upon interactions
with phospholipids (Brault et al., 1986). The association
kinetics of deuteroporphyrin with LDL can be described as
single exponentials. No evidence was found for slower
processes in stopped-flow experiments or upon conven-
tional fluorescence measurements after manual mixing. It
must be noted that the overall association constant K 
(5.8 1.2) 108 M1, measured at equilibrium, is close to
the ratio ka
obs/kd
obs, giving a value between 5.2  108 and
2.2  108 M1 as derived from the plots shown in Fig. 9.
It is expected that the population of the lipidic inner core of
LDL would be slower and could be distinguished kineti-
cally. Thus, it is very likely that the incorporation of deu-
teroporphyrin into LDL is limited to the outer layer of LDL
and sites close to the interface with the apoprotein.
This view is further supported by comparison of the value
of the affinity of deuterporphyrin for the lipidic components
of LDL and that for unilamellar lipidic vesicles. Compari-
son can be made on the basis of the number of phospholip-
ids molecules on the outer layer of LDL (800). The
affinity constant per phospholipid is calculated to be 2.5 
105 M1, a value of the same order of magnitude as the
value measured for unilamellar vesicles (Kuzelova and
Brault, 1994; Maman and Brault, 1998). We did not find
any increase of affinity that could indicate a significant
solubilization of the porphyrin in the LDL lipidic core.
Nevertheless, the affinity constant is fairly high, illustrating
the efficacy of LDL to carry lipophilic compounds. For
comparison, the affinity of meso-tetrakis(p-sulfonatophe-
nyl)porphyrin, a hydrophilic photosensitizer, for albumin is
around 1  106 M1 (Andrade and Costa, 2002).
The transfer of deuteroporphyrin to albumin gave further
information on the exit rate constants from the two classes
of sites of LDL. The third slow phase with a small ampli-
tude and a direction always opposite to that of the fast
components was unexpected. Numerical simulations show
that forth and back transfer from LDL to albumin could take
place with an appropriate combination of rate constants.
This process would arise if the exit rates for the two classes
of sites are very different, leading to a slow redistribution of
the porphyrin between LDL sites and HSA, but these sets of
rate constants would also predict biexponential kinetics for
the association of DP with LDL, which is not observed. The
slow phase might also be due to interactions between albu-
min and LDL, a phenomenon that was suggested elsewhere
(Ho et al., 1996) and that could also take place with lipo-
somes (Galantai et al., 2000). In any way, this phenomenon
represents10% of the observed signal. A detailed analysis
appears to be beyond the scope of the present study.
CONCLUSIONS
The present results give new insight into the role of LDL
particles as carriers of hydrophobic porphyrins. First, the
binding of the porphyrin to the apoprotein appears to be
limited and is not likely to involve the outer domain of the
apoprotein. As a matter of fact, the recognition of LDL by
their cellular receptor has been shown to be unaltered upon
binding of related porphyrins (Candide et al., 1986; de
Smidt et al., 1993). Second, the interactions of the porphyrin
with LDL particles are very fast compared to the rate of
lipopotein transport in biological fluids. At plasmatic phys-
iological LDL concentrations (7  106 M), the half-time
for association is 2  105 s and that for dissociation
between 0.05 and 0.12 s. Therefore, the transport of por-
phyrins by LDL must be considered as a dynamic process.
The distribution of the porphyrin among various carriers
will modify readily in response to a change in environment,
in particular that provided by the interstitial liquid of tumors
(Cunderlikova et al., 2000). Considering the rapidity of the
processes, exchange might even occur while the LDL par-
ticles are bound to their cellular receptor. The knowledge
and the control of the dynamics of photosensitizer LDL
association, which can extend to the design of covalent LDL
conjugates (Schmidt-Erfurth et al., 1997), are expected to
contribute significantly to the improvement of photosensi-
tizer targeting via the lipoprotein receptor pathway.
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